The anticonvulsant action of GABA-elevating agents: a re-evaluation.
D000498:Allyl Compounds / Q000494:pharmacology; D000613:Aminobutyrates / Q000378:metabolism*; D000625:Aminooxyacetic Acid / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D004353:Drug Evaluation, Preclinical; D005968:Glutamate Decarboxylase / Q000032:analysis; D006834:Hydrazines / Q000494:pharmacology; D006898:Hydroxylamines / Q000494:pharmacology; D006931:Hyperbaric Oxygenation; D007538:Isoniazid / Q000494:pharmacology; D008297:Male; D051379:Mice; D010433:Pentylenetetrazole / Q000494:pharmacology; D010852:Picrotoxin / Q000494:pharmacology; D012640:Seizures / Q000378:metabolism; D013268:Stimulation, Chemical; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D000498:Allyl Compounds; D000613:Aminobutyrates; D000625:Aminooxyacetic Acid; D000927:Anticonvulsants; D005968:Glutamate Decarboxylase; D006834:Hydrazines; D006898:Hydroxylamines; D007538:Isoniazid; D010433:Pentylenetetrazole; D010852:Picrotoxin; D005680:gamma-Aminobutyric Acid